Organization Overview
Alternative names
duvelisib (copiktra) (2018 NDA)
Adenocarcinoma (Phase 2)
Arthritis (Phase 2)
Arthritis, Rheumatoid (Phase 2)
Asthma (Phase 2)
Carcinoma, Non-Small-Cell Lung (Phase 2)
Carcinoma, Ovarian Epithelial (Phase 2)
Carcinoma, Squamous Cell (Phase 2)
Coronavirus Infections (Phase 2)
Head and Neck Neoplasms (Phase 1)
Leukemia (Phase 3)
Leukemia, Lymphocytic, Chronic, B-Cell (Phase 3)
Leukemia, Lymphoid (Phase 3)
Leukemia, Myeloid (Phase 1)
Leukemia, Myeloid, Acute (Phase 1)
Liver Diseases (Phase 1)
Lung Neoplasms (Phase 2)
Lymphoma (Phase 3)
Lymphoma, B-Cell (Phase 2)
Lymphoma, B-Cell, Marginal Zone (Phase 3)
Lymphoma, Follicular (Phase 3)
Lymphoma, Non-Hodgkin (Phase 3)
Lymphoma, T-Cell (Phase 2)
Lymphoma, T-Cell, Peripheral (Phase 2)
Melanoma (Phase 2)
Mesothelioma (Phase 2)
Neoplasm Metastasis (Phase 1)
Neoplasms (Phase 2)
Ovarian Neoplasms (Phase 2)
Pancreatic Neoplasms (Phase 2)
Pneumonia (Phase 2)
Prostatic Neoplasms (Phase 1)
Severe Acute Respiratory Syndrome (Phase 2)
Squamous Cell Carcinoma of Head and Neck (Phase 2)
Syndrome (Phase 2)